Results of a new study by UCLA researchers has found that a groundbreaking new triple combination therapy shows promising signs of more effectively controlling advanced melanoma than previous BRAF + MEK inhibitor or BRAF inhibitor + immunotherapy combos alone, and with increased immune response and fewer side effects.
from The Medical News http://ift.tt/1AOuZPn
from The Medical News http://ift.tt/1AOuZPn
No comments:
Post a Comment